×
About 79,086 results

ALLMedicine™ Anemia Center

Research & Reviews  37,041 results

Newer formulations of intravenous iron: a review of their chemistry and key safety aspe...
https://doi.org/10.1080/14740338.2021.1912010
Expert Opinion on Drug Safety; Blumenstein I, Shanbhag S et. al.

May 17th, 2021 - Introduction: The newest intravenous (IV) iron products show an improved safety profile over predecessors, allowing for the rapid administration of relatively high doses. Ferric derisomaltose (FDI; also known as iron isomaltoside), ferric carboxym...

Prevalence of Preoperative Iron Deficiency Anemia: A Case Series Among Patients Undergo...
https://doi.org/10.1213/XAA.0000000000001477
A&A Practice; Patel SY, Kubal TE et. al.

May 17th, 2021 - Anemia occurs in a significant group of patients with bladder cancer before radical cystectomy. Iron deficiency is a readily identifiable cause of anemia, which can be treated before surgery. The proportion of patients with bladder cancer with iro...

The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal...
https://doi.org/10.1002/cpt.2275
Clinical Pharmacology and Therapeutics; Tanaka M, Ikuma M et. al.

May 16th, 2021 - The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia.|2021|Tanaka M,Ikuma M,Asakura W,Fujiwara Y,|

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for ...
https://doi.org/10.1093/ibd/izab073
Inflammatory Bowel Diseases; Howaldt S, Domènech E et. al.

May 14th, 2021 - Iron-deficiency anemia is common in inflammatory bowel disease, requiring oral or intravenous iron replacement therapy. Treatment with standard oral irons is limited by poor absorption and gastrointestinal toxicity. Ferric maltol is an oral iron d...

see more →

Guidelines  157 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 11th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 30th, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 30th, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 18th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Meal Frequency and Skipping Breakfast Are Associated with Chronic Kidney Disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071178/
Nutrients Kim YJ,et al

Jan 26th, 2020 - Chronic kidney disease (CKD) is defined as structural or functional abnormalities of the kidney that affect health for more than 3 months. CKD is associated with cardiovascular disease, anemia, and metabolic bone disease, as well as adverse outcom...

see more →

Drugs  475 results see all →

Clinicaltrials.gov  39,051 results

Newer formulations of intravenous iron: a review of their chemistry and key safety aspe...
https://doi.org/10.1080/14740338.2021.1912010
Expert Opinion on Drug Safety; Blumenstein I, Shanbhag S et. al.

May 17th, 2021 - Introduction: The newest intravenous (IV) iron products show an improved safety profile over predecessors, allowing for the rapid administration of relatively high doses. Ferric derisomaltose (FDI; also known as iron isomaltoside), ferric carboxym...

Prevalence of Preoperative Iron Deficiency Anemia: A Case Series Among Patients Undergo...
https://doi.org/10.1213/XAA.0000000000001477
A&A Practice; Patel SY, Kubal TE et. al.

May 17th, 2021 - Anemia occurs in a significant group of patients with bladder cancer before radical cystectomy. Iron deficiency is a readily identifiable cause of anemia, which can be treated before surgery. The proportion of patients with bladder cancer with iro...

The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal...
https://doi.org/10.1002/cpt.2275
Clinical Pharmacology and Therapeutics; Tanaka M, Ikuma M et. al.

May 16th, 2021 - The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia.|2021|Tanaka M,Ikuma M,Asakura W,Fujiwara Y,|

EPO Treatment for Anemia Ups Fracture Risk in Patients on Dialysis
https://www.medscape.com/viewarticle/951273

May 16th, 2021 - Erythropoietin-stimulating agents — widely used to treat anemia in end-stage renal disease (ESRD) — increase the risk of hip fracture in patients on dialysis, and the higher the dose, the greater the risk, the first study of its kind indicates. In...

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for ...
https://doi.org/10.1093/ibd/izab073
Inflammatory Bowel Diseases; Howaldt S, Domènech E et. al.

May 14th, 2021 - Iron-deficiency anemia is common in inflammatory bowel disease, requiring oral or intravenous iron replacement therapy. Treatment with standard oral irons is limited by poor absorption and gastrointestinal toxicity. Ferric maltol is an oral iron d...

see more →

News  2,189 results

EPO Treatment for Anemia Ups Fracture Risk in Patients on Dialysis
https://www.medscape.com/viewarticle/951273

May 16th, 2021 - Erythropoietin-stimulating agents — widely used to treat anemia in end-stage renal disease (ESRD) — increase the risk of hip fracture in patients on dialysis, and the higher the dose, the greater the risk, the first study of its kind indicates. In...

Roxadustat Promise for Oral Treatment of Anemia in Kidney Disease
https://www.medscape.com/viewarticle/950979

May 11th, 2021 - Roxadustat — the furthest-advanced agent from a new oral drug class for treating anemia in patients with chronic kidney disease (CKD) — has now shown efficacy and safety in a sextet of phase 3 trials that collectively randomized more than 8000 pat...

Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain
https://www.medscape.com/viewarticle/950130

Apr 27th, 2021 - Oral vadadustat, one of a new class of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), is effective in the treatment of anemia in people with chronic kidney disease (CKD), but cardiovascular safety outcomes fall short of convent...

1 in 5 Hospitalized With Diabetic Ketoacidosis Is Readmitted
https://www.medscape.com/viewarticle/947922

Mar 22nd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

Fast Five Quiz: Iron Deficiency and Anemia in Heart Failure
https://reference.medscape.com/viewarticle/925290

Mar 14th, 2021 - Anemia is a frequent comorbidity among patients with heart failure. Its incidence ranges from 30% to 50% and is likely to be higher in certain populations. The presence of anemia is associated with increased symptoms and increased rates of hospita...

see more →

Patient Education  173 results see all →